FORT LAUDERDALE, Fla., June 14, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (MOTS), (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic ...
First case performed using the new FDA cleared Pure-Vu® EVS Gastro system, and expect to initiate broader market introductions by the end of 2023 Pure-Vu EVS Gastro addresses the Upper GI market, an ...
Researchers have demonstrated that a gut parasite suppresses inflammation and improves the health of the gastrointestinal system. The human gut -- or gastrointestinal system -- where food is broken ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results